Fred Hutchinson Cancer Research — Seattle, Washington

Fred Hutchinson Cancer Research is a clinical research site located in Seattle, Washington, United States 98109-1024.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Fred Hutchinson Cancer Research has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Neoplasms, Relapsed Multiple Myeloma, Refractory Multiple Myeloma.

Sponsors: USWM CT, LLC, Takeda, Amphivena Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fred Hutchinson Cancer Research?

Fred Hutchinson Cancer Research has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fred Hutchinson Cancer Research conducted?

Fred Hutchinson Cancer Research has 4 clinical trials on record, with 1 currently active. Their work covers Neoplasms, Relapsed Multiple Myeloma, Refractory Multiple Myeloma.

Is Fred Hutchinson Cancer Research accredited by Crixeo Health?

Yes — Fred Hutchinson Cancer Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Fred Hutchinson Cancer Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.